登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或者重大 遗漏。 特别提示： 1、案件所处的诉讼阶段：判决； 3、涉案的金额：50万元（与已缴纳的罚款九十万元折抵后，无需再行缴纳）； 4、对上市公司损益产生的影响：本次诉讼涉案金额较小，不会对公司2025年净利润产生重大影响。敬 请广大投资者关注公司在指定信息披露媒体上披露的相关公告，理性投资，注意投资风险。 一、本次诉讼事项受理的基本情况 公司于近日收到江苏森萱医药股份有限公司（以下简称"森萱医药"）转发的关于宁夏森萱的《刑事判决 书》（2025）宁8601刑初32号。 二、本诉讼事项的基本情况 （一） （原告/上诉人）基本信息： 姓名或名称：银川铁路运输检察院 2、上市公司所处的当事人地位：精华制药集团股份有限公司（以下简称"公司"）孙公司宁夏森萱药业 有限公司（以下简称"宁夏森萱"）为本次案件被告； 法定代表人/法定代理人/其他负责人：- 诉讼代理人及所属律所：周晓婷、暂无 （二） （被告/被上诉人）基本信息： 姓名或名称：宁夏森萱药业有限公司（被告一） 法定代表人/法定 ...

12月25日，精华制药（002349）公告称，公司于近日收到控股子公司江苏森萱医药股份有限公司（简 称"森萱医药"）转发的关于宁夏森萱药业有限公司（简称"宁夏森萱"）的《刑事判决书》。 公司孙公司宁夏森萱因污染环境罪被判处罚金50万元（罚金与该公司已缴纳的罚款90万元折抵后，无需 再行缴纳）；被告人黄雄虎（系宁夏森萱安环部部长）犯污染环境罪，判处有期徒刑二年六个月，缓刑 三年，并处罚金6万元。 图片来源：公司公告 公告显示，宁夏森萱为森萱医药子公司，精华制药孙公司。其生产农药医药中间体氟乙酸甲酯、氟乙酸 乙酯、氯乙酸甲酯、氯乙酸乙酯，为危险废物产废单位。黄雄虎系宁夏森萱安环部部长，非宁夏森萱、 森萱医药和公司董事、高管。 污染事件发生在2024年2月20日左右。彼时，因宁夏森萱所在的园区污水排放管道冻裂，无法处置废 水，负责安全环保的黄雄虎联系中间人贺某某和园区环境监管部门李某某，以320元每吨的价格，将宁 夏森萱废水处理站暂存池中未经处理的废水交由贺某某拉运到外地污水处理厂处置，贺某某组织拉运5 车约150吨废水直接倾倒在原石炭井一废弃学校院内，造成了环境污染。 图片来源：公司公告 银川铁路运输检察院认为， ...

Core Viewpoint - Jiangsu Senxuan Pharmaceutical Co., Ltd. announced that its subsidiary, Ningxia Senxuan Pharmaceutical Co., Ltd., and its safety and environmental protection department head, Huang Xionghu, are being prosecuted for environmental pollution, with a recommended fine of 400,000 to 600,000 yuan [1][4]. Group 1: Legal Proceedings - Ningxia Senxuan is a subsidiary of Jiangsu Senxuan, primarily engaged in the production of pesticide intermediates [3][8]. - The prosecution stems from an incident on February 20, 2024, where due to a frozen wastewater discharge pipeline, Huang Xionghu arranged for untreated wastewater to be illegally disposed of, resulting in the dumping of approximately 150 tons of toxic waste [3][8]. - The public prosecutor claims that this act caused property damage amounting to 857,897.97 yuan [3][8]. Group 2: Company Background and Operations - Ningxia Senxuan was established in November 2018 with a registered capital of 70 million yuan and is a subsidiary of the state-owned enterprise Jinghua Pharmaceutical Group [4]. - The company focuses on the research, production, and sales of pharmaceuticals and intermediates, with Lin Guoping as the legal representative and Zhu Shizhang as the chairman [4]. Group 3: Impact on Company Operations - Following the incident, the company has taken corrective actions, including ceasing operations for rectification, which was later approved by the local environmental authority for resumption of production [11]. - The company emphasizes its commitment to compliance and environmental protection, stating it will manage the situation proactively and maintain transparency regarding the legal proceedings [11]. Group 4: Financial Implications - As of the announcement date, the case has not yet gone to trial, and the exact fine amount remains uncertain [12]. - The company plans to handle the financial implications according to accounting standards and will disclose relevant information as required [12].

Group 1 - The company, Jinghua Pharmaceutical Group Co., Ltd., is involved in a legal case where its subsidiary, Ningxia Senxuan Pharmaceutical Co., Ltd., is the defendant in a lawsuit initiated by Yinchuan Railway Transportation Procuratorate [1][2] - The lawsuit concerns the illegal disposal of approximately 150 tons of toxic waste, resulting in damages amounting to 857,897.97 yuan [2] - The company holds a 72.31% stake in Senxuan Pharmaceutical, which in turn owns 51% of Ningxia Senxuan, indicating a significant ownership structure that may influence the company's financials [3] Group 2 - As of the announcement date, there are no other significant lawsuits or arbitration matters involving the company or its subsidiaries that require disclosure [3] - The potential impact of the lawsuit on the company's current and future profits is considered minimal, as the lawsuit amount is small and is not expected to significantly affect the company's net profit for 2025 [3]